Molecular Insight Names Peters CEO

5/13/09

Molecular Insight Pharmaceuticals (NASDAQ:MIPI) reports today it has a new president and CEO, Daniel Peters, who was previously president of the diagnostics division of GE Healthcare. Peters takes over the chief executive role from Molecular co-founder John Babich, who is staying with the Cambridge, MA-based firm as chief scientific officer in charge of research and development. Molecular is developing an imaging agent, Zemiva, for diagnosing lack of blood flow to the heart, or cardiac ischemia.

By posting a comment, you agree to our terms and conditions.